Aflac (AFL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
Zacks에서 열기
Aflac (AFL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Aflac (AFL) reported $4.22 billion in revenue for the quarter ended June 2026, representing a year-over-year decline of 6.9%. EPS of $1.75 for the same period compares to $1.78 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $4.19 billion, representing a surprise of +0.89%. The company delivered an EPS surprise of -1.13%, with the consensus EPS estimate being $1.77.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Aflac performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Total Benefit /Premium - Aflac Japan: 64% versus 61.7% estimated by three analysts on average. Total Adjusted Expenses/Total Adjusted Revenue - Aflac U.S.: 36.1% compared to the 37% average estimate based on three analysts. Total Benefit /Premium - Aflac U.S.: 49.5% versus the three-analyst average estimate of 49.2%. Total Adjusted Expenses/Total Adjusted Revenue - Aflac Japan: 20.2% versus the three-analyst average estimate of 20.7%. Total adjusted revenues- Aflac U.S.: $1.77 billion versus the three-analyst average estimate of $1.77 billion. The reported number represents a year-over-year change of +2.5%. Total adjusted revenues- Aflac Japan: $2.16 billion versus the three-analyst average estimate of $2.18 billion. The reported number represents a year-over-year change of -12.6%. Total adjusted revenues- Aflac U.S.- Total net earned premiums: $1.54 billion compared to the $1.54 billion average estimate based on three analysts. The reported number represents a change of +2.3% year over year. Total adjusted revenues- Aflac Japan- Other income: $8 million compared to the $7.91 million average estimate based on three analysts. The reported number represents a change of -33.3% year over year. Revenues- Other income (loss): $34 million versus the four-analyst average estimate of $29.44 million. The reported number represents a year-over-year change of +13.3%. Revenues- Net investment income: $984 million compared to the $918.03 million average estimate based on four analysts. The reported number represents a change of -9% year over year. Revenues- Total net earned premiums: $3.25 billion compared to the $3.25 billion average estimate based on four analysts. The reported number represents a change of -6.3% year over year. Total adjusted revenues- Corporate and other: $291 million versus $295.96 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -13.4% change.

View all Key Company Metrics for Aflac here>>>

Shares of Aflac have returned +3.4% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Aflac Incorporated (AFL): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research